You are here

ABT-414

AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT-414 for the Treatment of a Type of Pediatric Brain Tumor known as Diffuse Intrinsic Pontine Glioma (DIPG)

Yahoo

Mon, 07/11/16 - 09:17 am

Diffuse Intrinsic Pontine Glioma

AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting

Yahoo

Sun, 06/5/16 - 12:03 pm

Most Popular News Headlines For Thursday, August 14 2014

CP Wire

Fri, 08/15/14 - 06:19 am

Most popular news headlines for Thursday, August 14 2014

Fri, 08/15/14 - 06:18 am

AbbVie makes inroads in orphan drugs

Medical Marketing and Media

Thu, 08/14/14 - 08:45 am

glioblastoma multiforme

AbbVie heralds early success with its brain cancer-fighting armed antibody

Fierce Biotech

Fri, 05/30/14 - 01:07 pm

glioblastoma multiforme